These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12595189)

  • 1. Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load.
    Quarantelli M; Ciarmiello A; Morra VB; Orefice G; Larobina M; Lanzillo R; Schiavone V; Salvatore E; Alfano B; Brunetti A
    Neuroimage; 2003 Feb; 18(2):360-6. PubMed ID: 12595189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
    Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B
    Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.
    Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
    Neurology; 2005 Mar; 64(6):1001-7. PubMed ID: 15781816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
    De Stefano N; Matthews PM; Filippi M; Agosta F; De Luca M; Bartolozzi ML; Guidi L; Ghezzi A; Montanari E; Cifelli A; Federico A; Smith SM
    Neurology; 2003 Apr; 60(7):1157-62. PubMed ID: 12682324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.
    Horakova D; Cox JL; Havrdova E; Hussein S; Dolezal O; Cookfair D; Dwyer MG; Seidl Z; Bergsland N; Vaneckova M; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):407-14. PubMed ID: 17550987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalized regional brain atrophy measurements in multiple sclerosis.
    Zivadinov R; Locatelli L; Stival B; Bratina A; Grop A; Nasuelli D; Brnabic-Razmilic O; Zorzon M
    Neuroradiology; 2003 Nov; 45(11):793-8. PubMed ID: 14551760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.
    Inglese M; Ge Y; Filippi M; Falini A; Grossman RI; Gonen O
    Neuroimage; 2004 Apr; 21(4):1825-9. PubMed ID: 15050603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
    Sanfilipo MP; Benedict RH; Sharma J; Weinstock-Guttman B; Bakshi R
    Neuroimage; 2005 Jul; 26(4):1068-77. PubMed ID: 15961046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
    Megna R; Alfano B; Lanzillo R; Costabile T; Comerci M; Vacca G; Carotenuto A; Moccia M; Servillo G; Prinster A; Brescia Morra V; Quarantelli M
    J Neurol; 2019 Feb; 266(2):361-368. PubMed ID: 30498912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
    Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis.
    Riccitelli G; Rocca MA; Pagani E; Martinelli V; Radaelli M; Falini A; Comi G; Filippi M
    Mult Scler; 2012 Jul; 18(7):1027-37. PubMed ID: 22422807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.
    Dolezal O; Gabelic T; Horakova D; Bergsland N; Dwyer MG; Seidl Z; Krasensky J; Ramasamy DP; Vaneckova M; Havrdova E; Zivadinov R
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S42-8. PubMed ID: 24321154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain atrophy in clinically early relapsing-remitting multiple sclerosis.
    Chard DT; Griffin CM; Parker GJ; Kapoor R; Thompson AJ; Miller DH
    Brain; 2002 Feb; 125(Pt 2):327-37. PubMed ID: 11844733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.